Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Vertex Pharmaceuticals Incorporated (VRTX)

529.69 +8.66 (+1.66%)
At close: 4:00:00 PM EDT
540.01 +10.32 (+1.95%)
After hours: 6:32:04 PM EDT
Trade VRTX on Coinbase

News headlines

Updated 15m ago
Powered by Yahoo Scout

Vertex is approaching its November 2 Q3 earnings reportwith consensus estimates calling for $3.4 billion in revenueand $4.92 in EPS (earnings per share). Investors are weighing continued cystic fibrosis strength against the rollout of CASGEVY and JOURNAVX, plus Vertex’s effort to build kidney and endocrine businesses beyond its core franchise.

Mobilize your Website
View Site in Mobile | Classic
Share by: